Status:
COMPLETED
Induced Pluripotent Stem Cells for Disease Research
Lead Sponsor:
University of California, San Francisco
Conditions:
Hirschsprung Disease
Eligibility:
All Genders
13-100 years
Brief Summary
The aim of this study is to determine the contribution of genetic factors to the pathogenesis of diseases, including diseases such as Parkinson's disease, Hirschsprung's disease, and autism. Patient-d...
Eligibility Criteria
Inclusion
- Individuals with Hirschsprung disease
- Any disease severity accepted
- Individuals with or without other health issues accepted
- Unaffected / healthy relatives of individuals with Hirschsprung disease
Exclusion
- Individuals who are unwilling or unable to provide blood sample
- Individuals who are unwilling or unable to provide informed consent
- Individuals who are outside the age range permitted for our study will be excluded. Our study will only perform blood draws from individuals ages 13 and above.
Key Trial Info
Start Date :
April 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 3 2022
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT04476225
Start Date
April 15 2022
End Date
October 3 2022
Last Update
October 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94158